Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

  • The following term was not found in PubMed: Rodriguez-Licea.
1.

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions.

Castella M, Boronat A, Martín-Ibáñez R, Rodríguez V, Suñé G, Caballero M, Marzal B, Pérez-Amill L, Martín-Antonio B, Castaño J, Bueno C, Balagué O, González-Navarro EA, Serra-Pages C, Engel P, Vilella R, Benitez-Ribas D, Ortiz-Maldonado V, Cid J, Tabera J, Canals JM, Lozano M, Baumann T, Vilarrodona A, Trias E, Campo E, Menendez P, Urbano-Ispizua Á, Yagüe J, Pérez-Galán P, Rives S, Delgado J, Juan M.

Mol Ther Methods Clin Dev. 2018 Dec 6;12:134-144. doi: 10.1016/j.omtm.2018.11.010. eCollection 2019 Mar 15.

2.

Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma.

Castella M, Fernández de Larrea C, Martín-Antonio B.

Int J Mol Sci. 2018 Nov 15;19(11). pii: E3613. doi: 10.3390/ijms19113613. Review.

3.

CAR-T Cell Therapy: A Door Is Open to Find Innumerable Possibilities of Treatments for Cancer Patients

Perez-Amill L, Marzal B, Urbano-Ispizua A, Juan M, Martín-Antonio B.

Turk J Haematol. 2018 Nov 13;35(4):217-228. doi: 10.4274/tjh.2018.0196. Epub 2018 Sep 6. Review.

4.

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation.

Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502.

5.

Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.

Suárez-Lledó M, Martínez-Cibrián N, Gutiérrez-García G, Dimova-Svetoslavova V, Marcos MA, Martín-Antonio B, Martínez-Trillos A, Villamor N, Rosiñol L, Martínez C, Fernández-Avilés F, García-Vidal C, Urbano-Ispizua Á, Rovira M.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2088-2093. doi: 10.1016/j.bbmt.2018.05.001. Epub 2018 May 9.

PMID:
29753162
6.

Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Lozano E, Díaz T, Mena MP, Suñe G, Calvo X, Calderón M, Pérez-Amill L, Rodríguez V, Pérez-Galán P, Roué G, Cibeira MT, Rosiñol L, Isola I, Rodríguez-Lobato LG, Martin-Antonio B, Bladé J, Fernández de Larrea C.

J Immunol. 2018 Apr 15;200(8):2581-2591. doi: 10.4049/jimmunol.1701622. Epub 2018 Mar 12.

7.

Natural Killer Cells: Angels and Devils for Immunotherapy.

Martín-Antonio B, Suñe G, Perez-Amill L, Castella M, Urbano-Ispizua A.

Int J Mol Sci. 2017 Aug 29;18(9). pii: E1868. doi: 10.3390/ijms18091868. Review.

8.

The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.

Noriega V, Martínez-Laperche C, Buces E, Pion M, Sánchez-Hernández N, Martín-Antonio B, Guillem V, Bosch-Vizcaya A, Bento L, González-Rivera M, Balsalobre P, Kwon M, Serrano D, Gayoso J, de la Cámara R, Brunet S, Rojas-Contreras R, Nieto JB, Martínez C, Gónzalez M, Espigado I, Vallejo JC, Sampol A, Jiménez-Velasco A, Urbano-Ispizua A, Solano C, Gallardo D, Díez-Martín JL, Buño I; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH).

PLoS One. 2015 Oct 16;10(10):e0140454. doi: 10.1371/journal.pone.0140454. eCollection 2015.

9.

Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia.

Falantes JF, Trujillo P, Piruat JI, Calderón C, Márquez-Malaver FJ, Martín-Antonio B, Millán A, Gómez M, González J, Martino ML, Montero I, Parody R, Espigado I, Urbano-Ispizua A, Pérez-Simón JA.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):236-44. doi: 10.1016/j.clml.2014.10.003. Epub 2014 Oct 23.

PMID:
25487600
10.

Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking.

Martin-Antonio B, Najjar A, Robinson SN, Chew C, Li S, Yvon E, Thomas MW, Mc Niece I, Orlowski R, Muñoz-Pinedo C, Bueno C, Menendez P, Fernández de Larrea C, Urbano-Ispizua A, Shpall EJ, Shah N.

Cell Death Differ. 2015 Jan;22(1):96-107. doi: 10.1038/cdd.2014.120. Epub 2014 Aug 29.

11.

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Bueno C, Roldan M, Anguita E, Romero-Moya D, Martín-Antonio B, Rosu-Myles M, del Cañizo C, Campos F, García R, Gómez-Casares M, Fuster JL, Jurado M, Delgado M, Menendez P.

Haematologica. 2014 Jul;99(7):1168-75. doi: 10.3324/haematol.2014.103580. Epub 2014 Apr 11.

12.

Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.

Báez A, Martín-Antonio B, Piruat JI, Barbado MV, Prats C, Álvarez-Laderas I, Carmona M, Pérez-Simón JA, Urbano-Ispizua Á.

Biol Blood Marrow Transplant. 2014 May;20(5):630-9. doi: 10.1016/j.bbmt.2014.01.022. Epub 2014 Jan 23.

13.

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.

Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, Kaur I, Champlin RE, Bollard CM, Shpall EJ.

PLoS One. 2013 Oct 18;8(10):e76781. doi: 10.1371/journal.pone.0076781. eCollection 2013.

14.

Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.

Robinson SN, Thomas MW, Simmons PJ, Lu J, Yang H, Parmar S, Liu X, Shah N, Martín-Antonio B, Bollard C, Dotti G, Savoldo B, Cooper LJ, Najjar A, Rezvani K, Kaur I, McNiece IK, Champlin RE, Miller LP, Zweidler-McKay PA, Shpall EJ.

Cytotherapy. 2014 Jan;16(1):84-9. doi: 10.1016/j.jcyt.2013.07.003. Epub 2013 Oct 1.

15.

Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.

Báez A, Martín-Antonio B, Piruat JI, Prats C, Álvarez-Laderas I, Barbado MV, Carmona M, Urbano-Ispizua Á, Pérez-Simón JA.

Haematologica. 2014 Feb;99(2):243-51. doi: 10.3324/haematol.2013.086959. Epub 2013 Sep 20.

16.

Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion.

Isern J, Martín-Antonio B, Ghazanfari R, Martín AM, López JA, del Toro R, Sánchez-Aguilera A, Arranz L, Martín-Pérez D, Suárez-Lledó M, Marín P, Van Pel M, Fibbe WE, Vázquez J, Scheding S, Urbano-Ispizúa Á, Méndez-Ferrer S.

Cell Rep. 2013 May 30;3(5):1714-24. doi: 10.1016/j.celrep.2013.03.041. Epub 2013 Apr 25.

17.

A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT.

Martín-Antonio B, Suarez-Lledo M, Arroyes M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Gallardo D, Bosch A, Buño I, Martínez-Laperche C, Jiménez-Velasco A, de la Cámara R, Brunet S, Nieto JB, Urbano-Ispizua A.

Bone Marrow Transplant. 2013 Sep;48(9):1205-11. doi: 10.1038/bmt.2013.43. Epub 2013 Apr 1.

PMID:
23542224
18.

Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.

Fernández de Larrea C, Martín-Antonio B, Cibeira MT, Navarro A, Tovar N, Díaz T, Rosiñol L, Monzó M, Urbano-Ispizua A, Bladé J.

Leuk Res. 2013 Jun;37(6):641-6. doi: 10.1016/j.leukres.2013.01.013. Epub 2013 Feb 8.

PMID:
23395385
19.

A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT.

Martín-Antonio B, Álvarez-Laderas I, Cardesa R, Márquez-Malaver F, Baez A, Carmona M, Falantes J, Suarez-Lledo M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Urbano-Ispizua Á.

Bone Marrow Transplant. 2012 Sep;47(9):1206-11. doi: 10.1038/bmt.2011.253. Epub 2012 Jan 9.

PMID:
22231458
20.

Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation.

Martín-Antonio B, Granell M, Urbano-Ispizua A.

Expert Rev Hematol. 2010 Aug;3(4):411-27. doi: 10.1586/ehm.10.40. Review.

PMID:
21083033

Supplemental Content

Loading ...
Support Center